quranionline

Sam Rose Sam Rose

0 Course Enrolled • 0 Course Completed

Biography

CIC Exam Torrent - CBIC Certified Infection Control Exam Prep Torrent & CIC Test Braindumps

Our CIC training guide has been well known in the market. Almost all candidates know our CIC exam questions as a powerful brand. Once their classmates or colleagues need to prepare an exam, they will soon introduce them to choose our CIC Study Materials. So our study materials are helpful to your preparation of the CIC exam. As a matter of fact, we receive thousands of the warm feedbacks to thank us for helping them pass the exam.

If you want to get a good job, and if you are not satisfied with your present situation, if you long to have a higher station in life. We think it is high time for you to try your best to gain the CIC certification. Having our study materials, it will be very easy for you to get the certification in a short time. If you try purchase our study materials, you will find our CIC question torrent will be very useful for you. We are confident that you will be attracted to our CIC guide question.

>> CIC Best Vce <<

CBIC Certified Infection Control Exam Vce Torrent & CIC Test Practice Engine & CBIC Certified Infection Control Exam Latest Test Engine

When you choose CIC valid study pdf, you will get a chance to participate in the simulated exam before you take your actual test. The contents of CIC exam torrent are compiled by our experts through several times of verification and confirmation. So the CIC questions & answers are valid and reliable to use. You can find all the key points in the CIC practice torrent. Besides, the CIC test engine training equipped with various self-assessment functions like exam history, result scores and time setting, etc.

CBIC Certified Infection Control Exam Sample Questions (Q155-Q160):

NEW QUESTION # 155
A nurse claims to have acquired hepatitis A virus infection as the result of occupational exposure. The source patient had an admitting diagnosis of viral hepatitis. Further investigation of this incident reveals a 5-day interval between exposure and onset of symptoms in the nurse. The patient has immunoglobulin G antibodies to hepatitis A. From the evidence, the infection preventionist may correctly conclude which of the following?

A. The evidence at this time fails to support the nurse's claim.
B. The 5-day incubation period is consistent with hepatitis A virus transmission.
C. The patient has serologic evidence of recent hepatitis A viral infection.
D. The nurse should be given hepatitis A virus immunoglobulin.

Answer: A

Explanation:
The infection preventionist's (IP) best conclusion, based on the provided evidence, is that the evidence at this time fails to support the nurse's claim of acquiring hepatitis A virus (HAV) infection through occupational exposure. This conclusion is grounded in the clinical and epidemiological understanding of HAV, as aligned with the Certification Board of Infection Control and Epidemiology (CBIC) guidelines. Hepatitis A typically has an incubation period ranging from 15 to 50 days, with an average of approximately 28-30 days, following exposure to the virus (CBIC Practice Analysis, 2022, Domain I: Identification of Infectious Disease Processes, Competency 1.3 - Apply principles of epidemiology). The reported 5-day interval between exposure and symptom onset in the nurse is significantly shorter than the expected incubation period, making it inconsistent with HAV transmission. Additionally, the presence of immunoglobulin G (IgG) antibodies in the source patient indicates past exposure or immunity to HAV, rather than an active or recent infection, which would typically be associated with immunoglobulin M (IgM) antibodies during the acute phase.
Option A (the nurse should be given hepatitis A virus immunoglobulin) is not supported because post- exposure prophylaxis with HAV immunoglobulin is recommended only within 14 days of exposure to a confirmed case with active infection, and the evidence here does not confirm a recent exposure or active case.
Option C (the patient has serologic evidence of recent hepatitis A viral infection) is incorrect because IgG antibodies signify past infection or immunity, not a recent infection, which would require IgM antibodies.
Option D (the 5-day incubation period is consistent with hepatitis A virus transmission) is inaccurate due to the mismatch with the known incubation period of HAV.
The IP's role includes critically evaluating epidemiological data to determine the likelihood of transmission events. The discrepancy in the incubation period and the serologic status of the patient suggest that the nurse's claim may not be substantiated by the current evidence, necessitating further investigation rather than immediate intervention or acceptance of the claim. This aligns with CBIC's emphasis on accurate identification and investigation of infectious disease processes (CBIC Practice Analysis, 2022, Domain I:
Identification of Infectious Disease Processes, Competency 1.2 - Investigate suspected outbreaks or exposures).
References: CBIC Practice Analysis, 2022, Domain I: Identification of Infectious Disease Processes, Competencies 1.2 - Investigate suspected outbreaks or exposures, 1.3 - Apply principles of epidemiology.

NEW QUESTION # 156
The expectation to call out or speak up when an infection prevention lapse is observed is an example of

A. a safety culture with reciprocal accountability.
B. a blaming and shaming safety culture.
C. honest disclosure of a safety event.
D. implementation of human factors.

Answer: A

Explanation:
A safety culture withreciprocal accountabilityemphasizes mutual responsibility for maintaining safe practices, encouraging staff at all levels to "speak up" or "stop the line" when they observe risky practices.
This concept reflects a learning organization and a just culture that supports open communication and proactive risk mitigation.
* According to theAPIC Text, a strong safety culture is described as one where:
"The leadership can expect staff members to call out or stop the line when they see risk, and staff can expect leadership to listen and act." This dynamic reflects reciprocal accountability.
* Other options are less accurate:
* A. Human factorsrefer to system design, not behavioral accountability.
* B. Honest disclosure of a safety eventis about post-event transparency, not real-time intervention.
* C. A blaming and shaming cultureis antithetical to safety culture principles.
References:
APIC Text, 4th Edition, Chapter 18 - Patient Safety

NEW QUESTION # 157
Which of the following is an essential element of practice when sending biohazardous samples from one location to another?

A. Transport by an authorized biohazard transporter
B. Electronically log and send via overnight delivery
C. Ship using triple-containment packaging
D. Store in a cooler that is labeled as a health hazard

Answer: C

Explanation:
The safe transport of biohazardous samples, such as infectious agents, clinical specimens, or diagnostic materials, is a critical aspect of infection prevention and control to prevent exposure and environmental contamination. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes adherence to regulatory and safety standards in the "Prevention and Control of Infectious Diseases" domain, which includes proper handling and shipping of biohazardous materials. The primary guideline governing this practice is the U.S. Department of Transportation (DOT) Hazardous Materials Regulations (HMR) and the International Air Transport Association (IATA) Dangerous Goods Regulations, which align with global biosafety standards.
Option A, "Ship using triple-containment packaging," is the essential element of practice. Triple-containment packaging involves three layers: a primary watertight container holding the sample, a secondary leak-proof container with absorbent material, and an outer rigid packaging (e.g., a box) that meets shipping regulations.
This system ensures that biohazardous materials remain secure during transport, preventing leaks or breaches that could expose handlers or the public. The CDC and WHO endorse this method as a fundamental requirement for shipping Category A (high-risk) and Category B (moderate-risk) infectious substances, making it the cornerstone of safe transport practice.
Option B, "Electronically log and send via overnight delivery," is a useful administrative and logistical step to track shipments and ensure timely delivery, but it is not the essential element. While documentation and rapid delivery are important for maintaining chain of custody and sample integrity, they are secondary to the physical containment provided by triple packaging. Option C, "Transport by an authorized biohazard transporter," is a necessary step to comply with regulations, as only trained and certified transporters can handle biohazardous materials. However, this is contingent on proper packaging; without triple containment, transport authorization alone is insufficient. Option D, "Store in a cooler that is labeled as a health hazard," may be part of preparation (e.g., maintaining sample temperature), but labeling alone does not address the containment or transport safety required during shipment. Coolers are often used, but the focus on labeling as a health hazard is incomplete without the triple-containment structure.
The CBIC Practice Analysis (2022) supports compliance with federal and international shipping regulations, which prioritize triple-containment packaging as the foundational practice to mitigate risks. The CDC's Biosafety in Microbiological and Biomedical Laboratories (BMBL, 6th Edition, 2020) and IATA guidelines further specify that triple packaging is mandatory for all biohazardous shipments, reinforcing Option A as the correct answer.
References:
* CBIC Practice Analysis, 2022.
* CDC Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition, 2020.
* U.S. DOT Hazardous Materials Regulations (49 CFR Parts 171-180).
* IATA Dangerous Goods Regulations, 2023.

NEW QUESTION # 158
Which of the following processes is MOST important for the infection preventionist (IP) to review when evaluating a third-party reprocessor for single-use devices?

A. Observe all steps for reprocessing.
B. Obtain feedback from other IPs who use the reprocessor.
C. Review the facility's blueprints and policies.
D. Ensure air and water cultures are performed regularly.

Answer: A

Explanation:
The correct answer is A, "Observe all steps for reprocessing," as this is the most important process for the infection preventionist (IP) to review when evaluating a third-party reprocessor for single-use devices.
According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the reprocessing of single-use devices (SUDs) by third-party entities must adhere to stringent infection control standards to ensure they are safe for reuse and do not contribute to healthcare-associated infections (HAIs).
Observing all steps-such as cleaning, disinfection, sterilization, packaging, and quality control-allows the IP to directly assess compliance with manufacturer instructions, regulatory requirements (e.g., FDA guidelines), and best practices (e.g., AAMI ST91) (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment). This hands-on evaluation is critical because any deviation in the reprocessing chain can compromise device sterility and patient safety.
Option B (review the facility's blueprints and policies) provides context about the physical layout and procedural framework, but it is a preliminary step that does not directly verify the reprocessing process's effectiveness. Option C (ensure air and water cultures are performed regularly) is important for monitoring environmental contamination risks, particularly in sterile processing areas, but it is a supportive measure rather than the primary focus of evaluating the reprocessor's core activities. Option D (obtain feedback from other IPs who use the reprocessor) offers valuable peer insights, but it is subjective and secondary to direct observation, which provides firsthand evidence of compliance and performance.
The priority on observing reprocessing steps aligns with CBIC's emphasis on ensuring the safety and efficacy of reprocessed medical devices, a key responsibility for IPs when outsourcing to third-party reprocessors (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.5 - Evaluate the environment for infection risks). This process enables the IP to identify specific weaknesses, validate adherence to standards, and make informed decisions about the reprocessor's suitability.
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.3 - Ensure safe reprocessing of medical equipment, 3.5 - Evaluate the environment for infection risks. AAMI ST91:2015, Flexible and semi-rigid endoscope processing in health care facilities.

NEW QUESTION # 159
Which of the following individuals should be excluded from receiving live attenuated influenza virus?

A. Persons with allergies to chicken feathers
B. Healthy persons aged 2 to 49
C. Persons simultaneously receiving an inactivated vaccine
D. Pregnant persons

Answer: D

Explanation:
The correct answer is A, "Pregnant persons," as they should be excluded from receiving the live attenuated influenza virus (LAIV) vaccine. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, which align with recommendations from the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP), the LAIV, commonly known as the nasal spray flu vaccine, contains a live attenuated form of the influenza virus. This vaccine is contraindicated in pregnant individuals due to the theoretical risk of the attenuated virus replicating and potentially harming the fetus, despite limited evidence of adverse outcomes (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.2 - Implement measures to prevent transmission of infectious agents).
Pregnant persons are instead recommended to receive the inactivated influenza vaccine (IIV), which is considered safe during pregnancy.
Option B (healthy persons aged 2 to 49) is incorrect because this group is generally eligible to receive LAIV, provided they have no other contraindications, as the vaccine is approved for healthy, non-pregnant individuals in this age range (CDC Immunization Schedules, 2024). Option C (persons with allergies to chicken feathers) is not a contraindication for LAIV; the vaccine is produced in eggs, and while egg allergy was historically a concern, current guidelines indicate that LAIV can be administered to persons with egg allergies if they can tolerate egg in their diet, with precautions managed by healthcare providers. Option D (persons simultaneously receiving an inactivated vaccine) is also incorrect, as LAIV can be co-administered with inactivated vaccines without issue, according to ACIP recommendations, as there is no significant interference between the two vaccine types.
The exclusion of pregnant persons reflects CBIC's emphasis on tailoring infection prevention strategies, including vaccination programs, to protect vulnerable populations while minimizing risks (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.1 - Collaborate with organizational leaders). This decision is based on precautionary principles outlined in CDC and ACIP guidelines to ensure maternal and fetal safety (CDC Prevention and Control of Seasonal Influenza with Vaccines, 2023).
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.1 - Collaborate with organizational leaders, 3.2 - Implement measures to prevent transmission of infectious agents. CDC Prevention and Control of Seasonal Influenza with Vaccines, 2023. CDC Immunization Schedules, 2024.

NEW QUESTION # 160
......

The successful outcomes are appreciable after you getting our CIC exam prep. After buying our CIC latest material, the change of gaining success will be over 98 percent. Many exam candidates ascribe their success to our CIC real questions and become our regular customers eventually. Rather than blindly assiduous hardworking for amassing knowledge of computer, you can achieve success skillfully. They are masterpieces of experts who are willing to offer the most effective and accurate CIC Latest Material for you.

CIC Paper: https://www.briandumpsprep.com/CIC-prep-exam-braindumps.html

The BraindumpsPrep is committed to making the CBIC CIC exam preparation journey simple, smart, and swift, CBIC CIC Best Vce No other study materials can supersede the record-high pass rate, The 99% pass rate of CIC training vce will ensure you 100% pass, CBIC CIC Best Vce You also need to plan for your future, Don't worry about it now, our CIC materials have been trusted by thousands of candidates.

Reading and interpreting project network diagrams, When you visit the page, you must be going to attend the CIC Exam Test, or maybe you are the unfortunate person fail the CIC actual test.

Pass-Rate CIC Best Vce & Passing CIC Exam is No More a Challenging Task

The BraindumpsPrep is committed to making the CBIC CIC exam preparation journey simple, smart, and swift, No other study materials can supersede the record-high pass rate.

The 99% pass rate of CIC training vce will ensure you 100% pass, You also need to plan for your future, Don't worry about it now, our CIC materials have been trusted by thousands of candidates.

Hello world!

Sam Rose Sam Rose

Biography

Subscribe to our newsletter